Log in
Enquire now
Editas Medicine

Editas Medicine

Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/company/editas
B2X
B2B
B2B
0
B2C
B2C
Board of Directors
‌
David Scadden
0
‌
James Mullen
0
‌
GILMORE O’NEILL, M.B.
0
‌
emma reeve
0
Andrew Hirsch
Andrew Hirsch
0
CAGE Code
76VR5
0
CEO
‌
GILMORE O’NEILL, M.B.
0
CFO
‌
Michelle Robertson
0
CIK Number
1,650,664
0
Legal Name
Editas Medicine, Inc.
0
Company Operating Status
Active
Competitors
Exuma Biotechnology
Exuma Biotechnology
Pathway Genomics
Pathway Genomics
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...medicine
Date Incorporated
2013
DUNS Number
079328955
0
Email Address
info@editasmed.com
0
patients@editasmed.com
0
ir@editasmed.com
0
careers@editasmed.com
0
cristi.barnett@editasmed.com
0
Former CEO
‌
Cynthia Collins
Founded Date
2013
Founder
J. Keith Joung
J. Keith Joung
0
‌
Jennifer Doudna
Feng Zhang
Feng Zhang
George Church
George Church
Jennifer Doudna
Jennifer Doudna
Full Address
4909 Nautilus Court North Suite 208/211 Boulder, CO 80301
0
11 Hurley Street Cambridge, MA 02141 United States
0
Headquarters
Cambridge, Massachusetts
Cambridge, Massachusetts
0
Industry
Induced pluripotent stem cell
Induced pluripotent stem cell
Therapeutics
Therapeutics
Genetic engineering
Genetic engineering
Healthcare
Healthcare
CRISPR
CRISPR
Biomedical engineering
Biomedical engineering
Genomics
Genomics
0
Technology
Technology
RNA-based and RNA-targeted therapeutics
RNA-based and RNA-targeted therapeutics
Synthetic biology
Synthetic biology
•••
Investors
EcoR1 Capital
EcoR1 Capital
Fidelity Investments
Fidelity Investments
Khosla Ventures
Khosla Ventures
T. Rowe Price
T. Rowe Price
Jennison Associates
Jennison Associates
Google Ventures
Google Ventures
Partners Innovation Fund
Partners Innovation Fund
Viking Global Investors
Viking Global Investors
Omega Funds
Omega Funds
Polaris Partners
Polaris Partners
•••
IRS Number
464,097,528
0
Latest Funding Round Date
January 2021
Latest Funding Type
Series B
Series B
Legal classification
Corporation
Corporation
Public company
Public company
LinkedIn URL
@company/editas-medicine
Location
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
0
Boulder, Colorado
Boulder, Colorado
Colorado
Colorado
0
Number of Employees
264
0
Number of Employees (Ranges)
201 – 500
0
Patents Assigned (Count)
16
Phone Number
+16174019052
0
+16174010133
0
+16174019000
Pitchbook URL
pitchbook.com/profiles.../60465-97
Place of Incorporation
Delaware
Delaware
0
SIC Code
2,836
0
Exchange
Nasdaq
Nasdaq
0
Stock Symbol
EDIT
0
Technologies Used
CRISPR
CRISPR
Ticker Symbol
EDIT
Total Funding Amount (USD)
656,600,000
Twitter URL
@editasmed
Official Website
editasmedicine.com
Wellfound ID
editas
Wikidata ID
Q23131313

Find more companies like Editas Medicine

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.